Novo Nordisk launches Wegovy subscription for GLP-1 anti-obesity drugs
Wegovy semaglutide tablets. Michael Siluk | Universal Image Group | fake images Nordisk on Tuesday launched a multi-month subscription program…
Health
Discover the Latest Health, Medicine, Nutrition, and Fitness Tips for Women, Men, and Children
Stocks Soar on Hope for Iran War Resolution; In addition, Lilly suffers a big change in sleep disorders
Every weekday, the CNBC Investing Club with Jim Cramer publishes Homestretch, a helpful afternoon update just in time for the…
Eli Lilly reaches agreement to bring AI-developed medicines to the global market
A drone view shows the Eli Lilly logo at the company's office in San Diego, California, on November 21, 2025.…
AstraZeneca shares rise after surprise lung disease trial win
AstraZenecaShares rose more than 3% after Britain's most valuable company said its experimental drug for lung diseases met its target…
'Truly transformative' new diagnostic tools can help end tuberculosis
Tuberculosis is caused by a bacteria that most commonly affects the lungs. Every day, more than 3,300 people die from…
Sudan: Hospital attack highlights rise in drone attacks on civilians
The University Hospital in the East Darfur capital, Al Deain, was hit on Friday night, a new low in the…
Pfizer Lyme Disease Vaccine Fails in Trial, Company Will Seek FDA Approval
Thomas Fuller | Nurfoto | fake images Pfizer on Monday said it will seek regulatory approval for a Lyme disease…
Danone to buy protein shake maker Huel as healthy nutrition craze drives shift in demand
Huel makes powdered vegan meal replacements, aimed at people who “consider themselves time poor” but want healthy, environmentally sustainable meals.…
Menstrual product prices soar due to inflation and tariffs
Always products are displayed on a shelf in a supermarket in Sarajevo, Bosnia and Herzegovina, on October 29, 2024. Ruvic…
Eli Lilly's obesity drug retatrutide passes late-stage diabetes trial
The Eli Lilly logo appears at the company's office in San Diego, California, USA, on November 21, 2025. Mike Blake…